Listed

Kiora Pharmaceuticals Inc

KPRXNasdaqCIK 1372514HealthcareFiscal year ends Dec 31

Reports and events: 268 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Kiora Pharmaceuticals Inc, Reports and events
FiledFormWhat it isAccession number
2022-04-1509:06 ET10-KAnnual reportPeriod 2021-12-310001410578-22-000925
2022-03-2317:00 ET8-K5.02 Departure or appointment of officers or directors0001104659-22-037086
2022-02-2816:30 ET8-K3.01 Delisting notice; 5.02 Departure or appointment of officers or directors0001104659-22-028121
2022-02-1417:20 ET8-K5.02 Departure or appointment of officers or directors0001104659-22-023200
2022-02-0106:45 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-22-010000
2022-01-1117:58 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-22-002825
2021-12-1507:00 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-149776
2021-12-1407:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-149386
2021-11-1507:30 ET10-QQuarterly reportPeriod 2021-09-300001410578-21-000215
2021-11-0807:32 ET8-K5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-135333
2021-10-2607:00 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-129738
2021-09-1416:20 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-115504
2021-08-2616:16 ET8-K5.02 Departure or appointment of officers or directors0001104659-21-109807
2021-08-1216:19 ET10-QQuarterly reportPeriod 2021-06-300001104659-21-104182
2021-08-1006:55 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-102512
2021-08-0406:55 ET8-K5.02 Departure or appointment of officers or directors0001104659-21-099777
2021-08-0317:04 ETSC 13D/AOwnership report, active investor, amended0001011438-21-000187
2021-07-2616:18 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-095852
2021-06-2516:31 ET8-K5.07 Shareholder vote results0001104659-21-085746
2021-05-2707:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-072696
2021-05-1216:16 ET10-QQuarterly reportPeriod 2021-03-310001104659-21-065128
2021-04-3016:05 ETDEF 14AProxy statementPeriod 2021-06-240001104659-21-058990
2021-04-0106:55 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-045169
2021-03-2516:16 ET10-KAnnual reportPeriod 2020-12-310001104659-21-041515
2021-03-0516:15 ET8-K/A9.01 Financial statements and exhibits0001104659-21-032744
2021-02-0106:55 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-009669
2021-01-1217:08 ETSC 13D/AOwnership report, active investor, amended0000919574-21-000243
2021-01-0606:55 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-001243
2020-12-2106:55 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-137679
2020-11-0916:15 ET10-QQuarterly reportPeriod 2020-09-300001104659-20-123064
2020-09-1406:50 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-104579
2020-08-0616:15 ET10-QQuarterly reportPeriod 2020-06-300001104659-20-091445
2020-06-2616:16 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-20-077470
2020-06-0106:55 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-067975
2020-05-0616:16 ET10-QQuarterly reportPeriod 2020-03-310001104659-20-057438
2020-04-2916:14 ETDEF 14AProxy statementPeriod 2020-06-250001104659-20-053380
2020-03-3106:55 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-040798
2020-03-2416:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-20-037762
2020-03-0416:16 ET10-KAnnual reportPeriod 2019-12-310001104659-20-029162
2020-01-1516:46 ETSC 13D/AOwnership report, active investor, amended0000919574-20-000369
2020-01-1016:16 ET8-K5.02 Departure or appointment of officers or directors0001104659-20-003056
2020-01-1016:07 ETSC 13D/AOwnership report, active investor, amended0000919574-20-000308
2020-01-0317:08 ET8-K5.02 Departure or appointment of officers or directors0001104659-20-000963
2019-12-3116:05 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-077311
2019-12-1708:41 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-073250
2019-12-0306:55 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-19-069209
2019-12-0206:55 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-068757
2019-11-2206:55 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-066395
2019-11-0708:31 ET10-QQuarterly reportPeriod 2019-09-300001104659-19-060851
2019-10-1816:36 ETSC 13D/AOwnership report, active investor, amended0000919574-19-006500

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:43 ET. Listed shows no prices and gives no investment advice.